GILD vs HALO
Gilead Sciences, Inc. - Common Stock · Halozyme Therapeutics, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | GILD | HALO |
|---|---|---|
| Price | $156.19 | $121.84 |
| Market Cap | $193.67B | $13.83B |
| P/E | 22.76 | 43.64 |
| P/B | 16.37 | 96.34 |
| P/S | 6.58 | 9.90 |
| ROE | 71.9% | 220.8% |
| Net Margin | 28.9% | 22.7% |
| Gross Margin | — | — |
| Revenue Growth | 2.4% | 37.6% |
| Dividend Yield | 2.02% | — |
| EPS | $6.86 | $2.79 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.